SRF News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of SRF Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: SRF Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news and updates on SRF from all sources in a single place.

SRF Ltd.

16 Dec 2025

3090.30

1.30%

Company Update

SRF Ltd - 503806 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) …

BSE India

Pursuant to regulation 30 of SEBI (LODR) Regulations, 2015 read with Schedule III, Part-A, Para-B (Clause-8) we wish to inform the Stock exchanges about on Pending litigation/dispute

pdf

SRF Ltd.

15 Dec 2025

3090.30

1.30%

Chemical segment uptick to improve H2 growth for chemicals maker SRF

Business Standard

Based on global chemical firms' outlook, analysts expect SRF to continue to benefit from strong volume-led recovery in agrochem globally, resilient R32 demand & modest demand growth outlook

Number of FII/FPI investors increased from 670 to 679 in Sep 2025 qtr.

SRF Ltd.

08 Dec 2025

3090.30

1.30%

Upcycle across chemicals businesses; upside risk to consensus EPS

Buy: SRF Ltd.

Recommendation Target

ICICI Securities Limited

We remain sanguine on SRF’s chemicals business, with performance potentially improving across ref-gas, specialty chemicals and fluoropolymers. Higher volumes and sustained prices present ~15–20% upside risk in ref-gas business’ base-case revenues vs. a more plausible assessment.

Number of FII/FPI investors increased from 670 to 679 in Sep 2025 qtr.

SRF Ltd.

25 Nov 2025

3090.30

1.30%

Company Update

SRF Ltd - 503806 - Intimation Of Grant Of Options Under 'Part A - SRF Employees …

BSE India

Intimation of Grant of Options under ''Part-A- SRF Employees Stock Option Scheme, 2018 of SRF Long term Share based Incentives Plan, 2018 of the Company

pdf

SRF Ltd.

18 Nov 2025

3090.30

1.30%

5 stocks to avoid in current market; SRF, Devyani, 3 more may dip up to 15%

Business Standard

SRF, Devyani, Sumitomo have witnessed the formation of 'Death Cross', while Sona Coms and PI Industries saw a negative crossover on the MACD indicator, show the stocks daily chart.

ICICI Securities Limited upgraded SRF Ltd. to Buy with a price target of 3450.0 on 08 Dec, 2025.

SRF Ltd.

04 Nov 2025

3090.30

1.30%

Earnings Call

SRF Ltd - 503806 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Earnings Call held on 28th October 2025

pdf

SRF Ltd.

03 Nov 2025

3090.30

1.30%

SAST

SRF Ltd - 503806 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund

pdf

SRF Ltd.

31 Oct 2025

3090.30

1.30%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

Q2FY26 Chemicals Business drives growth- Revenues grew 6% YoY to 3,534.5 crore driven by the Chemicals business (46% of the revenues) which reported a growth of 23% YoY to 1,667 crore. While technical textiles (13% of the revenue) and Packaging films (39% of revenues) reported a decline of 11% and 1% to 474.3 crore and 1,408 crore respectively. Consolidated EBITDA stood at 774.2 crore, up 44% YoY, translating to margins of 21.3%, up ~560 bps YoY driven by the Chemical business (EBIT) which stood at 29%, up ~1100 bps YoY. Moreover, PAT for...

Number of FII/FPI investors increased from 670 to 679 in Sep 2025 qtr.

SRF Ltd.

29 Oct 2025

3090.30

1.30%

'Hold' SRF Shares Maintains Systematix Post Mixed Q2 Result, Trims Target Price; Sees Limited Upside Potential

NDTV Profit

While chemicals Ebit held the operating performance in line, the huge drag in packaging films business disappointed, adds the brokerage.

SRF has gained 35.31% in the last 1 Year

SRF Ltd.

29 Oct 2025

3090.30

1.30%

SRF's chemicals biz leads Q2 growth; analysts stay bullish; check targets

Business Standard

Brokerages maintained a positive stance on SRF, highlighting continued margin strength, steady volume growth, and the company's strategic capex expansion.